Highlights
NASDAQ: CYAD       Celyad Sa Ads
Last Price Today's Change   Day's Range   Trading Volume
11.99   +0.67 (5.92%)  11.371 - 11.99  29,500

Overview

 
Avg Volume (4 weeks):40,461
4 Weeks Range:8.48 - 12.28
4 Weeks Price Volatility (%):
92.37%
52 Weeks Range:8.10 - 23.20
52 Weeks Price Volatility (%):
25.76%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Celyad SA is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Corporate operating segments. It derives majority of its revenues from Cardiology segment.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers